New patent for Rhythm drug IMCIVREE
October 27, 2021 Comments Off on New patent for Rhythm drug IMCIVREE Posted in: Patent Added Annual Drug Patent Expirations for IMCIVREE Imcivree is a drug marketed by Rhythm and is included in one NDA. There are two patents protecting this drug. This drug has forty-three…
The post New patent for Rhythm drug IMCIVREE appeared first on DrugPatentWatch - Make Better Decisions.
Comments are closed.
New patent for Rhythm drug IMCIVREE
Comments Off on New patent for Rhythm drug IMCIVREE Posted in: Patent Added Annual Drug Patent Expirations for IMCIVREE Imcivree is a drug marketed by Rhythm and is included in one NDA. There are two patents protecting this drug. This drug has forty-three…
The post New patent for Rhythm drug IMCIVREE appeared first on DrugPatentWatch - Make Better Decisions.
Comments are closed.